+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Health care costs of therapy-refractory schizophrenic patients treated with clozapine: A study in a community psychiatric service in Italy



Health care costs of therapy-refractory schizophrenic patients treated with clozapine: A study in a community psychiatric service in Italy



Acta Psychiatrica Scandinavica 99(4): 274-280



This study evaluates the utilization of clozapine in the treatment of therapy-refractory schizophrenia in terms both of patterns of care and of health care costs in a community psychiatric service in Italy. Data covering the year prior to commencing clozapine and the year following the initiation of the therapy were collected. Clinical outcome was assessed by means of the Clinical Global Impression (CGI) and Global Assessment of Functioning (GAF) scales. Cost analysis followed a two-step procedure: (i) to record all health care services provided to patients and (ii) to assign a monetary value to each service. Three of the 15 patients enrolled in the study dropped out before the end of the 12-month period of therapy. Considering the 12 patients on clozapine treatment for at least 1 year, clinical improvements are associated with a substantial modification of the pattern of care. While patients in the pre-clozapine period were mainly managed in hospital settings, patients on clozapine were prevalently placed in the community and participated in intensive rehabilitative programmes. The higher costs of drug therapy and community services in the post-clozapine period were more than offset by the lower costs of acute hospital care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010736640

Download citation: RISBibTeXText

PMID: 10223430

DOI: 10.1111/j.1600-0447.1999.tb07225.x


Related references

Routine outcome monitoring in clinical practice: service and non-service costs of psychiatric patients attending a Community Mental Health Centre in Italy. European Psychiatry 19(8): 469-477, 2004

Mental Health Care in Italy: Organisational Structure, Routine Clinical Activity and Costs of a Community Psychiatric Service in Lombardy Region. International Journal of Social Psychiatry 46(4): 250-265, 2000

Mental health care in Italy: organisational structure, routine clinical activity and costs of a community psychiatric service in Lombardy region. International Journal of Social Psychiatry 46(4): 250-265, 2001

Service utilisation and costs of first-contact patients in a community psychiatric service in Italy. European Psychiatry 17(8): 434-442, 2002

Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. American Journal of Psychiatry 160(1): 169-171, 2002

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry. 34(10): 702-712, 1993

Which community care for patients with schizophrenic disorders? Packages of care provided by Departments of Mental Health in Lombardy (Italy). Epidemiologia E Psichiatria Sociale 16(4): 330-338, 2008

Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system. Journal of Clinical Psychiatry 59(4): 189-194, 1998

Multicenter study of patients treated in a community psychiatric health service. Acta Psychiatrica Belgica 86(5): 600-607, 1986

A One-Year Follow-Up of Patients with Acute Coronary Syndrome (Acs) and Diabetes Treated with Statins: Outcomes and Health Care Costs Supported by Italian National Health Service. Value in Health 18(7): A378-A379, 2015

Health care utilization and costs by site of service for nonmetastatic breast cancer patients treated with trastuzumab. Journal of Managed Care and Specialty Pharmacy 20(5): 485-493, 2015

Treatment patterns, health care resource utilization, and costs in patients with relapsed/refractory Hodgkin lymphoma treated with brentuximab vedotin. Leukemia and Lymphoma 2018: 1-8, 2018

Effects of clozapine on in vitro immune parameters of clozapine treated schizophrenic patients. Pharmacopsychiatry 30(5): 180, Sept, 1997

Service organisation, service use and costs of community mental health care. Journal of Mental Health Policy and Economics 5(2): 79-87, 2003

Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology 19(2): 114-122, 1998